Accession Number: | 0000899243-20-019088 |
Date: | 2020-06-22 |
Issuer: | 89BIO, INC. (ETNB) |
Original Submission Date: |
DIROCCO DEREK
C/O 89BIO, INC.
142 SANSOME STREET, 2ND FLOOR
SAN FRANCISCO, CA 94104
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 24.29 | 2020-06-22 | deemed execution date | A | 7,000 (a) | 2030-06-22 | common stock 7,000 | $24.29 | 7,000 | indirect | see footnote |
ID | footnote |
---|---|
f1 | this option represents a right to purchase a total of 7,000 shares of the issuer's common stock, which will vest in full on june 22, 2021, subject to the reporting person's continued service to the issuer through such date. |
f2 | under the reporting person's arrangement with ra capital management, l.p. (the "adviser"), the reporting person holds the option for the benefit of the ra capital healthcare fund, l.p. (the "fund"), ra capital nexus fund, l.p. (the "nexus fund") and a separately managed account (the "account"). the reporting person is obligated to turn over to the adviser any net cash or stock received from the option, which will offset advisory fees owed by the fund, the nexus fund and the account to the adviser. the reporting person therefore disclaims beneficial ownership of the option and underlying common stock. |